User profiles for Joachim Rudolph

Joachim Rudolph

- Verified email at gene.com - Cited by 5140

Joachim Rudolph

- Verified email at lsr.uni-saarland.de - Cited by 4375

Highly Efficient Epoxidation of Olefins Using Aqueous H2O2 and Catalytic Methyltrioxorhenium/Pyridine:  Pyridine-Mediated Ligand Acceleration

J Rudolph, KL Reddy, JP Chiang… - Journal of the American …, 1997 - ACS Publications
We report here the discovery of a ligand-accelerated1 mode for methyltrioxorhenium (MTO)-catalyzed
olefin epoxidations. 2, 3 Aqueous H2O2 is the oxidant, and the ligands are …

Flatness based control of a nonlinear chemical reactor model

R Rothfuss, J Rudolph, M Zeitz - Automatica, 1996 - Elsevier
The nonlinear model of a continuous stirred tank reactor is shown to be flat. The flatness
permits the design of suitable trajectories on the basis of the explicit stationary solution and the …

Control of flat systems by quasi-static feedback of generalized states

E Delaleau, J Rudolph - International Journal of Control, 1998 - Taylor & Francis
<p>Generalized states, the state representations of which depend on time derivatives of the
input, are naturally used in the control design for flat systems. Quasi-static feedback of these …

[HTML][HTML] Ras inhibition via direct Ras binding—is there a path forward?

W Wang, G Fang, J Rudolph - Bioorganic & medicinal chemistry letters, 2012 - Elsevier
Three decades after identification of the Ras oncogene, no effective treatments for Ras mutant
tumors are available despite intensive drug discovery efforts. Here we critically review the …

Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity

…, I Mellman, PK Jackson, J Rudolph… - Proceedings of the …, 2012 - National Acad Sciences
The Ras gene is frequently mutated in cancer, and mutant Ras drives tumorigenesis. Although
Ras is a central oncogene, small molecules that bind to Ras in a well-defined manner …

Phenotypic screening in cancer drug discovery—past, present and future

JG Moffat, J Rudolph, D Bailey - Nature reviews Drug discovery, 2014 - nature.com
There has been a resurgence of interest in the use of phenotypic screens in drug discovery
as an alternative to target-focused approaches. Given that oncology is currently the most …

Small-molecule ghrelin receptor antagonists improve glucose tolerance, suppress appetite, and promote weight loss

WP Esler, J Rudolph, TH Claus, W Tang… - …, 2007 - academic.oup.com
Ghrelin, through action on its receptor, GH secretagogue receptor type 1a (GHS-R1a),
exerts a variety of metabolic functions including stimulation of appetite and weight gain and …

seco-Cyclothialidines:  New Concise Synthesis, Inhibitory Activity toward Bacterial and Human DNA Topoisomerases, and Antibacterial Properties

J Rudolph, H Theis, R Hanke… - Journal of medicinal …, 2001 - ACS Publications
seco-Cyclothialidines are a promising class of bacterial DNA gyrase B subunit inhibitors. A
new seco-cyclothialidine derivative containing a dioxazine moiety, BAY 50-7952, was …

[BOOK][B] Flatness based control of distributed parameter systems

J Rudolph - 2003 - researchgate.net
Joachim RudolphRudolph, Joachim: Flatness Based Control of Distributed Parameter
Systems / Joachim Rudolph. Aachen : Shaker, 2003 …

Expanding chemical probe space: quality criteria for covalent and degrader probes

IV Hartung, J Rudolph, MM Mader… - Journal of Medicinal …, 2023 - ACS Publications
Within druggable target space, new small-molecule modalities, particularly covalent inhibitors
and targeted degraders, have expanded the repertoire of medicinal chemists. Molecules …